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Extracellular matrix (ECM)' plays an important regulatory role in cellular
growth, migration, and differentiation (1-4) . Pathologic processes such as tumor
cell invasion and metastasis are also determined by cellular interactions with
ECM (5, 6) . Biochemical studies have identified collagens, fibronectin, laminin,
proteoglycans, and several other proteins as majorECM components (1-3), and
have shown that ECM composition varies between different normal and tumor
tissues . The complexity and heterogeneity of ECM composition have hampered
the molecular analysis ofECM-cell interactions . However, a range of phenotypic
changes has been described for cultured cells after transfer from plastic surfaces
to substrates coated with native ECM (7, 8) or with purified ECM components ;
ECM-induced phenotypic changes include enhanced substrate adhesiveness, cell
spreading and migration, changes in cell morphology and proliferative activity,
and expression of differentiated cellular functions (I-4). Some of these effects,
e.g ., increased substrate adhesion, may result directly from the binding of
specialized cell surface structures to ECM molecules . Others are likely mediated
by an active cellular response triggered by the interaction of ECM with cell
surface receptors . Thus, ECM-derived signals (9) may activate a cascade of
molecular changes within the cell and on the cell surface that account for the
pleiotropic effects observed with ECM.
To investigate molecular changes on the cell surface that are controlled by
ECM-cell interactions, we have compared patterns of cell surface antigen expres-
sion on cells cultured on ECM-coated substrates with those of cells cultured on
plastic surfaces . In a previous study (10), we described the first example of a
human cell surface antigen, a chondroitin sulfate proteoglycan designated as
me]-CSPG, that is specifically induced by ECM . These earlier observations were
made through analysis of a series of mouse-human neuroblastoma hybrids that
are uniquely responsive to ECM . They show a rapid change in substrate adhe-
siveness, cell spreading, and cell morphology when transferred from plastic
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surfaces to substrates coated with ECM secreted by bovine corneal endothelial
cells (BCE-ECM). Concomitantly, hybrids that have retained the mel-CSPG-
encoding human chromosome 15 show induction of mel-CSPG surface expres-
sion (10). Other cell types, which do not show the characteristic changes in cell
morphology and growth behavior when cultured on ECM, also lack ECM-
inducible me]-CSPG expression (10). In the present study, we have exploited the
neuroblastoma hybrid system to identify two additional human cell surface
glycoproteins modulated by BCE-ECM and purified ECM components. Our
findings indicate that ECM-derived signals play a regulatory role analogous to
that played by cytokines and other soluble factors in determining differentiated
cellular phenotypes and patterns of surface antigen expression.
Materials and Methods
Cell Lines.
￿
Human tumor cell lines were taken from the cell line collection maintained
at Sloan-Kettering Institute; neuroblastoma cell lines were obtained from Dr. J. L. Biedler
(Sloan-Kettering Institute), IARC-EW1 cellsfrom Dr. G. Lenoir (International Association
for Research on Cancer, Lyon, France), and RD-ES and IMR-32 from the American Type
Culture Collection (Rockville, MD). Cell lines were grown in DME or DME/Ham's F12
(1 :1) supplemented with 2 mM glutamine, 1% nonessential amino acids, 100 U/ml
penicillin, 100 Atg/ml streptomycin, and 7 .5% FCS; 15% FCS was supplemented for
neuroblastoma cell lines. Normal skin melanocyte cultures (11) were provided by Dr. A.
N . Houghton, and cultures of normal kidney epithelial cells by Dr. N . Bander (Sloan-
Kettering Institute). Rodent-human somatic cell hybrids were generated as described (10,
12-15) and human chromosomes retained in hybrid cells were determined by karyotype
analysis and typing for human isozymes and cell surface antigens (10, 12-16).
Monoclonal Antibodies.
￿
mAb A42 (IgG2b) was derived from a (BALB/c X C57BL/6)F,
mouse immunized with SK-OV-3 cells following standard fusion, hybrid selection, and
cloning procedures. mAbJ143, A010, and A0122 have been described (13, 17) and the
W6/32 clone was obtained from the American Type Culture Collection. A single batch
of each mAb was used throughout this study.
Serologic Procedures.
￿
mAb-mediated erythrocyte rosetting assays for detection of cell
surface antigens on cultured cells have been described (17-19). Briefly, cells grown in 60-
well MicroWell plates (Nunc, Roskilde, Denmark) for 24-48 h were incubated with serial
dilutions of mAb for 1 h. After repeated washes, cells were incubated for 45 min with
indicator cells, prepared by conjugating human type O erythrocytes with purified rabbit
anti-mouse Ig (Dako Corp ., Santa Barbara, CA) using chromium chloride. Plates were
then washed and scored microscopically by determining the proportion of target cells
showing attachment of indicator cells (erythrocyte rosetting). All cell lines were tested
with serial dilutions ofmAb (starting dilution 1 :1,000 nu/nuserum or ascites) to determine
highest dilutions giving rosette formation (titration endpoints).
Immunochemical Procedures.
￿
Cells were labeled with [s5S]methionine or ['H]glucosa-
mine (New England Nuclear, Boston, MA) and extracted with NP-40 buffer. For some
experiments, lysates were separated after labeling on a Con A-Sepharose column. Alter-
natively, cell membranes were "'I-labeled by the chloramine-T method (17). Immuno-
precipitation experiments, SDS-PAGE, and fluorography were carried out as described
(17).
Cell Culture on ECM-coated Substrates. Plastic dishes and 60-well MicroWell plates
coated with BCE-ECM (7), were purchased from International Biotechnologies (Jerusalem,
Israel). Fibronectin (FN)-coated substrates were prepared by incubating plastic dishes and
60-well MicroWell plates (Nunc) with purified human plasma FN (20) at 50 ,ug/ml for 1
h at 37°C; FN was kindly provided by Dr. J. Sorvillo (Sloan-Kettering Institute). Recon-
stituted basement membrane gel from the Engelbrecht-Holm-Swarm tumor (EHS-BM; 8)
was purchased from Collaborative Research (Matrigel, Lexington,' MA) and used accord-
ing to the manufacturer's instructions for cell culture on a thin layer of Matrigel. ForRETTIG ET AL .
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FIGURE 1 .
￿
Fluorogram of immunoprecipitates obtained with mAb A42 from NP-40 lysates
of metabolically labeled astrocytoma cells and separated by SDS-PAGE. SK-MG-10 (lanes 1-
4), U251MG (lanes 5 and 6) and SK-GS-1 cells (lanes 7 and 8) were labeled with [sH]-
glucosamine, extracted with NP-40-containing buffer, and aliquots with equal sH counts per
minute, as determined after precipitation of cellular proteins from cell lysates with 10% TCA,
were used in experiments with mAb A42 (lanes 1, 3, 5, and 7) or unrelated control mAb
(lanes 2, 4, 6, and 8) . Protein separation by SDS-PAGE was carried out under reducing
conditions (extraction buffer containing 12 mg/ml DTT) in all experiments except for
experiment shown in lanes 3 and 4 (extraction buffer containing 14 mg/ml iodoacetamide) .
Film exposure times for fluorography were 7 d for experiments shown in lanes 1-6 and 21 d
for experiment shown in lanes 7 and 8 . M, of immunoprecipitated components (x10-3) are
indicated on the right,
serologic assays in 60-well MicroWell plates coated with BCE-ECM, FN, or EHS-BM,
target cells were seeded at 300 cells/well and cultured for 24-48 h at 37°C in a 5% C02
humidified air atmosphere before erythrocyte rosetting assays .
Results
A42 Surface Expression on Human Cells.
￿
mAb A42 recognizes a cell surface
glycoprotein that migrates with an Mr of 57,000 on SDS-polyacrylamide gels in
the presence of reducing agents, and atM, 66,000 under nonreducing conditions
(Figs . 1 and 2A). The 57,000 A42 glycoprotein was detected in immunoprecip-
itation experiments with a number of cell types belonging to different cell
lineages, including astrocytomas (SK-MG-1, SK-MG-2, SK-MG-10, SK-MG-15,
U251MG), melanomas (SK-MEL-28, SK-MEL-37), simian virus 40 (SV40)-trans-
formed WI-38 fibroblasts, A10 epithelial cancer cells, and normal kidney epithe-
lial cells . Identical components were precipitated with mAb A42 using three
different labeling procedures : metabolic incorporation of [3H]glucosamine or
["S]methionine, and ' 21I-labeling ofCon A-bound cell membrane fractions .
Serial dilutions of mAb A42 were tested by erythrocyte rosetting assays for
surface reactivity with a large panel of cultured human cell types (Table 1), and
titration endpointsweredetermined in triplicate for all antigen-positive cell lines,
with variation between individual test results not exceeding a single fivefold
titration step . Differences in titration endpoints between A42+ cell lines closely
paralleled the results of immunoprecipitation experiments as illustrated in Fig .
1 for three astrocytoma cell lines. Consistent with previous findings (21, 22) that
had shown that erythrocyte rosetting assays are highly sensitive for detection of
small numbers of surface antigen molecules per cell, some cell lines were found1584 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
FIGURE 2 .
￿
Fluorogram of immunoprecipitates obtained with mAbs to cell surface antigens
A42andJ143 and separatedby SDS-PAGE . (A) Extracts of ['H]glucosamine-labeled SK-MEL-
37 (lanes 1-3), SK-MEL-23 (lane 4), LAI-5s (lanes 5 and 6) and LA-N-In cells (lane 7) were
tested with mAbA42 (lanes 1, 3-5, and 7) or with unrelated control mAb (lanes 2and 6) . (B)
Extracts of [sH]glucosamine-labeled LAI-5s (lanes 1-3), LA-N-In (lane 4), and EWls cells
(lanes 5 and 6) were tested withmAbAJ2 (lane 1), mAbJ143 (lanes 2, 4, and 5), or unrelated
control mAb (lanes 3 and 6) ; all immunoprecipitates shown were separated under reducing
conditions except for experiment shown in A, lane 3, whichwas carried out undernonreducing
conditions .
to type A42+ in rosetting assays but lack detectable antigen by immunoprecipi-
tation tests (compare results with SK-GS-1 cells in Table I and Fig . 1) . A highly
characteristic pattern of antigen expression was observed with cells that share a
common neuroectodermal origin . Thus, A42 is strongly expressed on fetal and
newborn skin melanocytes but is not detected on adult skin melanocytes . Simi-
larly, a subset of melanoma cell lines (6 of 13 lines tested) are strongly reactive
with mAb A42, whereas the remaining seven melanomas are antigen-negative
(Table I) . These results for cell surface expression were confirmed by immuno-
precipitation tests (Fig . 2A) showing that the A42 glycoprotein is detectable in
SK-MEL-28 and SK-MEL-37 but not SK-MEL-23 melanoma cell extracts . Com-
parison of the A42' and A42- melanoma subsets for expression of known
differentiation markers of melanocytic cells (Table 11) revealed a close correlation
between A42 phenotype and stage of cellular differentiation, with A42' mela-
nomas resembling fetal and newborn skin melanocytes and A42- melanomas
resembling adult skin melanocytes . Thus, A42+ melanomas typically express
HLA-DR and epidermal growth factor receptors (EGF-R), but not the M144
andTA99 differentiation antigens ofmature melanocytic cells, have an epithelial
morphology and lack pigmentation . In contrast, A42- melanomas are typically
pigmented, have a spindle-shaped or polydendritic morphology, and express
M144 and TA99 but not HLA-DR and EGF-R (Table 1I).
Cell surface expression of A42 also distinguishes other cell types that share a
common neuroectodermal origin with melanocytic cells . Astrocytomas are A42+
whereas neuroblastomas and retinoblastomas are A42- (Table I) . Ewing's sar-
coma cells and normal and transformed cells of lymphoid or myeloid origin areRETTIG ET AL.
TABLE I
Reactivity ofmAb A42 with Cell Surface Antigens ofCultured Human Cells
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Numbers indicate reciprocal of highest mAb dilution (X 10-') giving rosette formation with target
cells in erythrocyte rosetting assays. Dash indicates no rosette formation at starting dilution of
mAb.
* Fibroblasts derived from adult lung, skin, and kidney, and from fetal lung and skin.
t Peripheral blood lymphocytes separated by Ficoll gradient centrifugation.
also A42-. However, typing results with mesenchymal and epithelial cells show
that A42 expression is not restricted to neuroectoderm-derived cells because
normal skin and lung fibroblasts and kidney epithelial cells are strongly reactive
with mAb A42 (Table I). In addition to the A42- neuroblastoma and Ewing's
sarcoma lines listed in Table I, we have tested morphologic variants derived
from several of these cell lines for A42 expression. The predominant cell type
in neuroblastoma cultures is characterized by a small, round cell body that may
extend neuritic processes, contain dense-core vesicles, and show enzyme activities
for neurotransmitter synthesis (23, 24). This neuronal phenotype (n-variants)
can be distinguished from the epithelial or fibroblast-like morphology of large,
flattened, substrate-adherent cells (s-variants) that arise spontaneously in a pro-
portion of cell lines (24, 25), but which remain a minor cell population in
unselected cultures. The s-variant cells do not extend neuritic processes and
show no or little neurotransmitter synthetic activity, thus lacking neuronal
properties . Pure n-variant and s-variant cultures have been obtained, and cyto-
genetic evidence has indicated a common clonal origin for variants in a given
cell line (23, 26). Paired variants derived from three neuroblastomas, SK-N-
Cell type
Target cells
Designation
A42 reactivity
(titer X 10-')
Normal cells
Skin meianocytes
Adult Short-term culture -
Fetal, newborn Short-term culture 625
Fibroblasts* Short-term culture 625
Kidney epithelial cells Short-term culture 3,125
Lymphocytest -
Transformed cells
Melanoma SK-MEL-I3, -28, -37, -131 3,125
SK-MEL-31, -173 625
SK-MEL-19, -23, -26, -29
SK-MEL-127, -l53, McWo
Neuroblastoma SK-N-BE(1), -BE(2), NAP
CHP234, IMR-32, LA-N-1
SMS-KAN, -SAN, -KCN
Retinoblastoma Y79, Weri
Astrocytoma SK-MG-10, -15 15,625
SK-MG-1, -2, -3, -17, U251MG 3,125
SK-GS-1 25
Ewing's sarcoma IARC-EW1, RD-ES -
T cell leukemia MOLT-4, T45, CCRF-CEM, -HSB2 -
B cell leukemia SK-LY-16, -18, Daudi, Raji -
Myeloid leukemia HL-60, K562 -
EBV` B cells DX-B, FD-B, AH-B, BD-B -1586 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
TABLE II
Comparative Analysis ofHuman Melanoma Cell Linesfor Antigen Expression,
Cell Morphology, and Degree ofPigmentation
For typing results with mAb A42, see Table I; for morphology, pigmentation, and expression of
HLA-DR, M114, EGF-R, and TA99, see Houghton et al. (11), Real et al. (22), and Thomson et
al. (36). NT, not tested.
* Cell morphology indicated as follows: E, epithelioid; S, spindle-shaped; D, polydendritic.
$ Pigmentation assessed as described (11): -, nonpigmented; +/-, weak pigmentation, generally
limited to cultures at high cell densities; + to +++, moderate to very strong pigmentation.
BE(2), SK-N-SH, and LA-N-1, were available for this study and were tested for
A42 expression. All three n-variants, BE(2)-88n, SH-EP15, and LA-N-In, were
found to be A42-. In contrast, the three s-variants, BE(2)-88s, SH-EP1, and
LA1-5s, show strong reactivity with mAb A42 (Fig. 3), and the 57,000 M, A42
glycoprotein is detected in immunoprecipitation experiments with s-variant cells
but not n-variant cells (Fig. 2A). Spontaneous morphologic variant formation,
sitvtilar to that seen in the neuroblastoma cultures, is also observed in two cell
lines derived from human Ewing's sarcomas, namely RD-ES and IARC-EW1 .
When grown on plastic culture dishes, RD-ES and IARC-EW1 cells are predom-
inantly small and round or polygonal, and either grow in tightly packed clusters
of floating cells or are loosely substrate-adherent, piling up into aggregates of
viable cells at high cell density (Fig. 4). We have now identified strongly substrate-
adherent variant cells in cultures of these two cell lines that are characterized by
an epithelial or fibroblast morphology, and purified variant cell cultures, desig-
nated as EW Is, have been obtained from the IARC-EW1 line (Fig. 4) . When
tested for changes in cell surface antigen expression, EW ls cells were found to
newly express the A42 antigen (Fig. 3).
J143 Surface Expression on Human Cells.
￿
mAb J143 recognizes a cell surface
glycoprotein complex, composed of disulfide-linked subunits of 140,000 and
30,000 M,, that is noncovalently associated on the surface ofJ143' cells with an
additional 140,000 Mr surface glycoprotein, detected by mAb AJ2 (13) . The
J143 cell surface antigen is strongly expressed on most cultured human cell types
growing as substrate-adherent monolayers, but is not or only weakly expressed
on cells growing in suspension culture or loosely substrate-adherent (13) . In the
Melanoma cell line
A42
Antigenic system
HLA-DR EGF-R M144 TA99
Morphol-
ogy*
Pigmenta-
tiont
SK-MEL-37 + + + - - E -
SK-MEL-173 + + + - - E-S -
SK-MEL-31 + - + - - E +/-
SK-MEL-131 + + + - - S -
SK-MEL-13 + + + - - S +/-
SK-MEL-28 + + + - + E-S +/-
SK-MEL-153 - + NT - NT S +
SK-MEL-26 - - NT + NT E-S -
SK-MEL-29 - + + + - S +/-
SK-MEL-127 - + NT + + S-D +
McWo - - - + + S +
SK-MEL-19 - - - + + S-D ++
SK-MEL-23 - - - - + S +++RETTIG ET AL.
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FIGURE 3.
￿
Differential expression ofcell surface antigens A42, J143, AO10,and mel-CSPG
on human neuroblastoma and Ewing's sarcoma variants determined by erythrocyte rosetting
assays. (A) mAb A42 (O, 0) andJ143 ([1, 0) tested with IACR-EW1 Ewing's sarcoma cells
(0,p) and the derived substrate-adherent EW Is variant cells (0, 0). (B) mAb A42 (O, ") and
J143 (p,/) tested with n-variant BE(2)-88n neuroblastomacells (O,0) and substrate-adherent
BE(2)-88s variants (0, "). (C) mAb AO10 (O, ") and A0122, detecting met-CSPG (A, A)
tested with IARC-EW1 (O, ") and Ewls cells
￿
A). (D) mAb AO10 (O, ") and (AO122
(A, A) tested with BE(2)-88n (O, A) and BE(2)-88scells (", A).
present study, the BE(2)-88n and BE(2)-88s neuroblastoma variants and the
IARC-EW1 and EW1s sarcoma variants, respectively, were compared for J143
cell surface expression. Fig. 3 shows that in both systems the substrate-adherent
variants are strongly reactive with mAbJ143, whereas the n-variant or parental
cells are unreactive or only weakly reactive with this mAb. Consistent with these
findings for cell surface expression, mAb J143 was found to precipitate the
characteristic 140,000 M, glycoprotein from the substrate-adherent variant cells
but not from the loosely substrate-adherent cell types (Fig. 2B).
A42 and J143 Surface Expression on Rodent-Human Hybrid Cells.
￿
mAb A42
andJ143 do not react with the rodent cells used for construction ofsomatic cell
hybrids but they do react with distinct subsets of the panel of 57 hybrid clones
included in this study. We have determined through immunoprecipitation ex-
periments that mAb A42 recognizes the characteristic 57,000 Mr glycoprotein
and mAb J143 recognizes the 140,000 Mr glycoprotein in antigen-expressing
hybrid cells (clones A9/DXB6 and NSK-3, respectively). Three types of A42+ or
J143' hybrids were distinguished: (a) hybrids derived from fusions between
antigen-expressing human cells and permissive' rodent cell types (Table 111,
group 1); (b) hybrids derived from antigen-negative human cells and inducing
rodent cell types (Table 111, group 11); and (c) human neuroblastoma-derived
hybrids that are conditionally antigen expressing; they do not express A42 or
2 Rodent cells are termed permissive for expression ofahumanantigenwhen hybrids constructed
with antigen-positive human cells are found to express the antigen, and inducing when hybrids
constructed with antigen-negative human cells express the antigen; for a previous discussion see
reference 13.1588 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
FIGURE 4.
￿
Morphology of Ewing's sarcoma cells in culture . (A) IACR-EW1 cells grown on
plastic; (B) EWIs variant cells grown on plastic ; (C) RD-ES cells grown on plastic, showing
floating cell aggregates ; (D) RD-ES cells grown on FN-coated substrate ; (E) IARC-EWI cells
grownon BCE-ECM;and (F) IARC-EW 1 cellsgrown on EHS-BM, showing substrate-attached
cell aggregates . Photomicrographs were taken 24 h after transfer of cells from plastic flasks to
new culture vessels .
J143 when grown on plastic substrates but they are induced to express the
antigens when grown on BCE-ECM or FN (see below) .
A comparison between the serologic typing results and the distribution of
individual human chromosomes among the hybrid clones permitted the chro-
mosomal assignment ofgene loci controllingA42 andJ143 expression . TheJ143
gene has previously been assigned to human chromosome 17822-gter (13) and
the results of this study confirm this assignment. Discordancy analysis for the
A42 antigen (Table IV) shows that the presence of no single human chromosome
is both necessary and sufficient for antigen expression in hybrid cells (column
marked total number of discordancies) . Only two human chromosomes, 6 and
14, are present in all A42+ hybrid clones ; the presence of no other human
chromosome is required for antigen expression as indicated by ?4 (and mostlyRETTIG ET AL.
￿
1559
TABLE III
A42 and J143 Cell Surface Expression on a Panel ofRodent-Human Somatic
Cell Hybrids Derivedfrom Fusions between Different Human and Rodent
Cell Lines Tested by Erythrocyte Rosetting Assays
Cell lines RAG, A9, and LTK are of mouse origin and cell lines YH21, E36, and V79 are of
hamster origin.
* Results for A42 andJ143 typing only shown for hybrids containing relevant human chromosomes,
namely chromosomes 6 and 14 for A42andchromosome 17 forJ143 (see Results).
$ GroupI hybrid combinations define permissive rodent phenotypeandgroupII hybrid combinations
define inducing rodent phenotype (13).
>10) discordant hybrid clones (column labeled A42+/chromosome-negative).
However, two independently derived hybrid clones retaining human chromo-
some 6 and eight clones retaining human chromosome 14 lack A42 expression
(column marked A42-/chromosome-positive), indicating that neither chromo-
some by itself is sufficient for antigen expression . Therefore, we have examined
the possibility that concomitant presence of two (or more) different human
chromosomes is required for A42 expression . A single combination of human
chromosomes, namely, 6 and 14, was found to show cosegregation with A42 cell
surface expression; all other combinations of human chromosomes showed at
least five discordancies with A42 expression in the hybrid panel.
ECM-modulated Cell Surface Expression ofA42 andJ143.
￿
In ourprevious work
(10) we showed that a number of NBE and NSK neuroblastoma hybrids show
coordinate changes in substrate adhesiveness, cell spreading, cell morphology,
and surface antigen expression when cultured on BCE-ECM instead of plastic
surfaces. To examine the effects of specific culture substrates on A42 andJ143
expression, we have compared the antigenic phenotypes of 11 neuroblastoma
hybrid clones (NBE-C2, -D4, -E 1, -GI, -HI, J2, -K 1, -MI, -N 1, NSK-4, and
NSK-6), grown either on plastic dishes or on dishes coated with BCE-ECM or
purified plasma FN. All I 1 hybrid clones showed a rapid change in cell mor-
phology and substrate adhesiveness after transfer from plastic dishes to BCE-
Human parent
Cell type
Phenotype
A42 J143
Rodent parent
Hybrid
Name
clone
Phenotype*
A42 J143
Group I$
Kidney epithelial cell + + RAG kidney cancer RC2/11 +
Fibroblast + + A9 fibroblast AFib3 +
Fibroblast + + RAG kidney cancer RFibI +
SK-MEL-28 melanoma + + YH21 fibroblast CE12 +
SK-MEL-131 melanoma + + YH21 fibroblast CC4/1 + +
Kidney epithelial cell + + RAG kidney cancer RC5 +
Kidney epithelial cell + + LTK fibroblast LNK1/6 +
GroupIII
EBV+ B cell - - A9 fibroblast A9/DXB6 +
Lymphocyte - - RAGkidney cancer G1711K +
Lymphocyte - - E36 fibroblast G35K +
SK-MEL-29 melanoma - + YH21 fibroblast CW29 +
Lymphocyte - - V79 fibroblast VLym-5 +
SK-N-MC neuroblastoma - - LTK fibroblast LMC2 +1590 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
TABLE IV
Discordancy Analysisfor Chromosomal Assignment ofHuman Gene
Loci Determining A42 Cell Surface Expression in a Panel of 54
Hybrid Clones
Numbers in body of table refer to numbers of hybrid clones expressing
A42butlacking humanchromosome listed on theleft (A42'/chromosome-
negative), numbers of hybrid clones containing respective human chro-
mosome but lacking A42 (A42-/chromosome-positive), or total numbers
of discordant hybrid clones.
ECM or FN, and Fig. 5 illustrates these changes for NBE-G1 and NSK-6 hybrid
cells cultured on FN-coated substrates. When tested for changes in cell surface
antigen expression, clones NBE-El, NBE-Gl, NBE-Ml, and NSK-4, which
contain human chromosomes 6and 14 (but notchromosome 17), show induction
of A42 expression, while clones NBE-H1 and NSK-6, which contain human
chromosome 17 (but not chromosomes 6 and 14), show induction of J143
expression (Fig. 6).
A range of A42-,J 143- human cell types were cultured on BCE-ECM and FN
to search for human cell lines that are similarly responsive to ECM-derived
signals. Neuroblastomas, retinoblastomas, and a number of hematopoietic cell
types tested did not show any changes in cell morphology or induction of A42
or J143 surface expression . However, two Ewing's sarcoma lines, IARC-EW1
and RD-ES responded to culture on both BCE-ECM and FN with greatly
increased substrate adhesiveness and cell spreading, forming confluent well-
Human
chromosome
Number
A42'/chromo-
some-negative
of discordant hybrid
A42-/chromo-
some-positive
clones
Total
1 11 6 17
2 25 3 28
3 16 8 24
4 15 6 21
5 13 5 18
6 0 2 2
7 17 3 20
8 17 5 22
9 22 3 25
10 17 7 24
11 18 6 24
12 14 6 20
13 19 6 25
14 0 8 8
15 10 12 22
16 18 6 24
17 15 8 23
18 20 5 25
19 21 4 25
20 11 11 22
21 4 14 18
22 20 7 27
X 7 14 21
Y 25 3 28RETTIG ET AL .
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FIGURE 5 . Comparison of cell morphology, cell spreading, and substrate adherence of
mouse-human neuroblastoma hybrid cell lines, NSK-6 and NBE-G1, cultured on plastic
surfaces or FN-coated substrates. (A) NSK-6 cells grown on plastic for 90 min after transfer,
showing round cell morphology and no cell spreading . (B) Same cell culture as shown in A;
culture waswashed with PBS and cells remaining in flaskwere incubated with PBS for 15 min
at 37°C, and subsequently gently washed twice with PBS to remove detached cells . After
addition of culture media photomicrograph was taken, showing loss of >_95% of cells . (C)
NSK-6 cells grown on FN-coated substrate ; photomicrograph taken after 90 min of culture
and subsequent washes with PBS exactly as described above for B. No significant loss of cells
(<5%) and no change in epithelial-like morphology of hybrid cells. (C) NBE-G1 cells grown
on plastic for90 min ; round cells showingno cell spreading . (E)NBE-G1 cellsgrown on plastic
for 90 min and subsequently washed with PBS exactly as described for B; loss of >95% of
cells . (F) NBE-G1 cells grown on FN-coated substrate for90 min followed by washes with PBS
as above ; no significant loss of cells (<5%) or change in epithelial-like morphology .
attached monolayers of epithelial-like cells instead of the loosely substrate-
adherent or floating cell aggregates seen on plastic culture surfaces (Fig . 4) . In
contrast, when IARC-EW 1 and RD-EScells were transferred to substrates coated
with EHS-BM they formed large cellular aggregates that were strongly adherent
to the culture substrate but did not form monolayers (Fig. 4) . Comparison of
IARC-EW 1 cells cultured on plastic or on FN, BCE-ECM, or EHS-BM showed1592 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
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FIGURE 6.
￿
Induction of A42 andJ143 cell surface expression in mouse-human neuroblas-
toma hybrids cultured on plastic surfaces versus substrates coated with FN. mAb A42 (top
panels) andJ143 (bottom panels)were tested by erythrocyte rosetting assays with hybrid clones
NBE-EI (0), NBE-GI (0), NBE-HI (0), and NSK-6(M); clones NBE-E1 and NBE-GI contain
human chromosomes 6 and 14, clones NBE-H1 and NSK-6 contain human chromosome 17.
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FIGURE 7 .
￿
Expression of cell surface antigens A42(0),J143 (/), HLA-A,B,C(O), me]-CSPG
(0), S4 (CI), and F23 (A) on IARC-EWI cells grown for 24 h on substrates coated with EHS-
BM, FN, or BCE-ECM, respectively, and determined by erythrocyte rosetting assays. Serotyp-
ing results for IARC-EW1 cells grown on plastic surfaces were identical to those shown for
cells grown on EHS-BM.
that A42 andJ143 are specifically induced by FN and BCE-ECM (Fig. 7) but not
by EHS-BM. To further show that A42 and J143 are specifically induced by
BCE-ECM and FN, we examined IARC-EW1 cells grown on different substrates
for changes in the expression of several unrelated cell surface antigens, including
me]-CSPG (detected by mAb A0122 [10)), HLA-A,B,C (detected by mAb
W6/32), S4 (18), and F23 (13). We found no changes in the expression of theseRETTIG
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antigens
when IARC-EW 1 cells were transferred from plastic surfaces to BCE-
ECM,
FN, or EHS-BM-coated substrates (Fig
.
7)
.
Discussion
Cell
surface antigens with restricted tissue distribution have been used as
markers
for (a) cells derived from a common cell lineage (27, 28), (b) cells at
specific
stages of differentiation within a cell lineage (11, 28), and (c) cells
activated
by mitogens or differentiating factors (29-34)
.
A large proportion of
antigens
that show a differentiation stage-specific pattern of expression or are
modulated
by differentiating factors and mitogens in one cell lineage have also
been
found in unrelated cell lineages with apparently different patterns of
regulation
and expression (28-32, 35)
.
In the present study, we describe two cell
surface
molecules, A42 and J 143, that are expressed in a stage-specific pattern
on
neural and melanocytic cells, but are not restricted to these two neuroecto-
derm-derived
cell lineages
.
Furthermore, we report that cell surface expression
of
both molecules is modulated by extrinsic differentiation factors, and that A42
and
J143, like the previously described cell surface proteoglycan, mel-CSPG (10),
belong
to a novel class of cell-ECM interaction molecules, namely ECM-modu-
lated
cell surface glycoconjugates
.
To determine the function of the A42 and
J143
glycoproteins, it will be of interest to study their possible role in cell
spreading
or morphological differentiation
.
A42 and J143 may also function as
receptors
for ECM components, with cell surface expression being upregulated
by
ligand binding
.
Because multiple receptor/ligand systems are known to be
involved
in cell adhesion, such a role for A42 and 1143 is not ruled out by our
finding
that neither mAb A42 nor mAb J143 blocks substrate attachment of
antigen-expressing
cells (unpublished results)
.
Houghton
et al
.
(11) have shown that cultured fetal and newborn skin mela-
nocytes
differ from adult melanocytes in cell morphology, degree of pigmenta-
tion,
and pattern of cell surface antigen expression, and that these distinct
melanocyte
phenotypes are conserved or reexpressed in subsets of established
melanoma
cell lines
.
Thus, fetal and newborn melanocytes (and a putative
melanocyte
precursor), as well as poorly differentiated melanoma cells, show an
epithelial
or spindle-shaped morphology, no or little pigmentation, low tyrosinase
levels,
and an HLA-DR', EGF-R+, M 144-, TA99- antigenic phenotype, whereas
adult
melanocytes and well-differentiated melanomas show dendritic morphol-
ogy,
strong pigmentation, high tyrosinase levels, and HLA-DR-, EGF-R-,
M
144+, TA99+ phenotype (11, 22, 36)
.
The results of the present study show
that
A42 belongs to the group of early melanocyte differentiation markers, and
that
A42 expression on normal and transformed melanocytic cells closely follows
the
pattern predicted by the scheme of melanocyte differentiation proposed by
Houghton
et al
.
(11)
.
In contrast, J143 is equally expressed on fetal and adult
melanocytes
and on all melanoma cell lines
.
However, differential expression of
A42
and J 143 on neuroblastoma variants, retinoblastomas, and astrocytomas, all
of
which share a common neuroectodermal origin with melanocytic cells, suggests
that
both A42 and J 143 are neural differentiation antigens
.
A more definitive
placement
of these findings in a scheme of neuronal and glial differentiation
awaits
the analysis of normal antigenic phenotypes of cultured human neurons1594 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
and astrocytes. Interestingly, the close linkage observed between variant forma-
tion and A42 and J143 expression in neuroblastoma and Ewing's sarcoma cell
lines (but not other cell types) is in agreement with recent evidence suggesting a
common neuroectodermal origin for both types of tumor cell lines (37).
Somatic cell genetic analysis has provided several types of information con-
cerning the organization of genes encoding cell surface molecules within the
human genome and regulatory signals determining the expression of antigens
with restricted tissue distribution . First, a large number of gene loci coding for
human cell surface antigens has been chromosomally mapped (38) and, in all
previous instances (including HLA antigens, see below), a single human gene
locus has been found to determine antigen expression in hybrid cells. A42
antigen appears to follow a novel pattern, being determined by two separate
human gene loci on chromosomes 6 and 14. Most likely, one gene encodes the
A42 polypeptide and the second gene may encode an A42-associated molecule
or direct steps in the processing or intracellular targeting of the A42 molecule
(neither surface-A42- human nor hybrid cells show detectable intracellular
antigen when tested by immunoprecipitation assays or immunofluorescence tests
of permeabilized cells; unpublished observations). Cell surface expression of
human HLA class I antigens shows some analogies to the A42 antigenic system
in that it also depends on two gene loci, the HLA heavy chain locus on
chromosome 6 and the N2-microglobulin locus on chromosome 15 (39) and cell
surface expression of HLA molecules in rodent-human hybrids requires the
synthesis of #2-microglobulin in hybrid cells containing HLA genes (40, 41).
However, rodent ,02-microglobulin is capable of substituting for its human
homologue (42) and masks the two-gene requirement. The observation of an
increase of 9,000 in the M, of the A42 glycopeptide under nonreducing condi-
tions raises the possibility that the 57,000 M, molecule may be linked by disulfide
bonds to an as yet unidentified second subunit. Alternatively, a noncovalently
linked A42-associated molecule may have remained undetected due to dissocia-
tion during cell extraction procedures.
The second type of information derived from somatic cell genetic analysis is
the identification of regulatory controls determining surface antigen expression.
Previous studies have shown that the differentiation program of the rodent
fusion partner determines the expression of a number of introduced human
genes, presumably through intrinsic, trans-acting signals. For instance, cell
surface expression of human EGF-R (43), nerve growth factor receptor (16),
HLA-DR (44), me]-CSPG (10), and the F23 and JF23 glycoproteins (13) has
been described in rodent-human hybrids derived from fusions between antigen-
negative human cells and appropriate rodent cell types (inducing rodent pheno-
type). Conversely, lack of human Thy-1 and MC139 expression has been de-
scribed (14) in a subset of hybrids derived from antigen-expressing human cells
that have retained the Thy-1 and MC139 encoding human chromosome 11
(nonpermissive rodent phenotype). In the present study we show that A42 and
J143 are two new examples of inducible human cell surface antigens. The
molecular nature of the intrinsic, inducing, or restricting signals is not known;
conceivably, they are provided by the rodent recipient cell, or, alternatively,RETTIG ET AL.
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result from the loss of human signals through chromosome segregation or
inhibition in the rodent recipient cell .
In addition to these intrinsic regulatory signals, a number of extrinsic signals
have been shown to modulate surface antigenic phenotypes (29-34). In the case
of the A42 andJ143 antigens, surface expression was found to be modulated by
ECM-derivedextrinsic signals, and together with mel-CSPG (10), these glycopro-
teins represent the first examples of human cell surface molecules regulated in
this way. Previous studies with soluble differentiation factors and mitogens have
provided precedents for extrinsic control of surface antigenic phenotype. For
instance, IFN-y is known to induce HLA class I and class II antigen expression
in many cell types (31, 32, 45); tumor necrosis factor induces HLA class I
expression (30); and mitogens and lymphokines modulate surface antigen expres-
sion in distinct lymphocyte subsets (29). We propose that ECM-derived signals
play a similar role in determining antigenic phenotypes, as has been defined for
solublefactors. Specificity of the ECM-derived signals may stem from the variable
composition of the matrix surrounding cells in vivo or from selective expression
of individual ECM receptors in cells of different cell lineages or cells at distinct
stages of differentiation within a cell lineage. Because A42 and 1143 expression
in the ECM-responsive neuroblastoma hybrids and IARC-EW1 cells is induced
by biochemically complex native BCE-ECM and also by purified plasma FN, it
will be possible now to examine which of the known domains of the FN molecule
carry regulatory signals and whether A42 andJ143 are modulated by the same
signals. Based on the results of this and previous studies (10), it seems likely that
divergent molecular mechanisms control cell adhesion, cell spreading, cell mor-
phology, and expression of specific cell surface antigens in ECM-responsive cells,
and that the diverse phenotypic effects of ECM are target cell-specific. For
instance, BCM-ECM is equally effective in changing cell morphology and growth
characteristics in neuroblastoma hybrids and in IARC-EW1 cells but induction
of mel-CSPG expression is seen only in neuroblastoma hybrids (10) and not in
IARC-EW1 cells. Furthermore, BCE-ECM and FN-induced changes in cell-
substrate adhesion and cell spreading are observed within 1-2 h after transfer
from plastic surfaces, whereas induction of A42 andJ143 cell surface expression
is first detected after 12-24 h (Figs. 5 and 6; unpublished results). Finally, EHS-
BM promotes substrate adhesion of Ewing's sarcoma cell aggregates but not cell
spreading or A42/J143 surface expression in these cells (Figs. 5 and 7).
The diversity of ECM-controlled traits and the fact that the genes encoding
the three known ECM-modulated cell surface antigens, A42, J143, and mel-
CSPG, are located on different human chromosomes suggest that the ECM-
derived signalsactivate target cell-specific programs of alternative differentiation
rather than the expression of single gene products. Characterization of the
distinct ECM signals, the ECM receptors, andthe intracellularsignalling pathways
controlling A42, J143, and mel-CSPG will be important next steps in our analysis
of extrinsic signals that govern tissue-specific patterns of cell surface antigen
expression .1596 EXTRACELLULAR MATRIX-MODULATED CELL SURFACE GLYCOPROTEINS
Summary
We have used serologic, biochemical, and genetic methods to characterize two
stage-specific human differentiation antigens of neural and melanocytic cells:
A42 (57,000 M, glycoprotein) and J143 (140,000/30,000 M, glycoprotein). The
genes determining A42 and J143 cell surface expression in rodent-human
hybrids were chromosomally mapped, and the respective human chromosomes
were introduced into rodent cells derived from distinct differentiation lineages.
Serologic analysis of the resulting hybrid clones has permitted the identification
of two types of regulatory signals determining A42 and J143 expression. First,
both antigens are expressed in hybrids constructed with antigen-positive human
cells and also in certain hybrids constructed with antigen-negative human cells,
indicating that intrinsic signals provided by the differentiation program of the
rodent fusion partner induce antigen expression . Second, a series of human-
mouse neuroblastoma hybrids, which are A42- or J143- when cultured on plastic
surfaces, can be induced to express the antigens when cultured on substrates
coated with extracellular matrix (ECM) produced by bovine corneal endothelial
cells or fibronectin . This induction of antigen expression by extrinsic, ECM-
derived signals is accompanied in the neuroblastoma hybrids by increased sub-
strate adhesiveness and cell spreading and by characteristic changes in cell
morphology. A similar program ofphenotypic changes is also seen in spontaneous
variants of human neuroblastoma and Ewing's sarcoma cells and in ECM-induced
Ewing's sarcoma cells . These findings suggest that ECM-derived signals have a
role analogous to mitogens and soluble differentiation factors in modulating
differentiation phenotypes and tissue-specific patterns of cell surface antigen
expression .
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